New treatment option for Postoperative Atrial Fibrillation
Official title Diagnosis of Atrial Fibrillation in Postoperative Thoracic Surgery Using a Smartwatch
ClinicalTrials.gov ID: NCT06724718
What this study is testing
- What it's testing
- Postoperative atrial fibrillation (POAF) occurs in approximately 20% of patients following thoracic surgery. Early diagnosis is essential to prevent complications such as heart failure, stroke, myocardial infarction, and increased mortality.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Adults (\>18 years old).
- Patients undergoing major thoracic surgery with one-lung ventilation within the past 48 hours.
- Scheduled pneumonectomy or lobectomy.
- Admission to a conventional surgical unit postoperatively.
- Ability to perform single-lead ECG using a smartwatch.
You likely can't join if
- History of atrial fibrillation.
- Requirement for telemetry for AV block or tachyarrhythmias (\>140 bpm).
- Dependency on a pacemaker.
- Participation in another treatment clinical trial affecting POAF incidence.
- Mediastinal, pleural, or chest wall surgery.
- Reoperations or surgeries performed more than 48 hours prior.
See the full eligibility criteria
- Adults (\>18 years old).
- Patients undergoing major thoracic surgery with one-lung ventilation within the past 48 hours.
- Scheduled pneumonectomy or lobectomy.
- Admission to a conventional surgical unit postoperatively.
- Ability to perform single-lead ECG using a smartwatch.
- Coverage under a social security system.
- Signed informed consent
- History of atrial fibrillation.
- Requirement for telemetry for AV block or tachyarrhythmias (\>140 bpm).
- Dependency on a pacemaker.
- Participation in another treatment clinical trial affecting POAF incidence.
- Mediastinal, pleural, or chest wall surgery.
- Reoperations or surgeries performed more than 48 hours prior.
- Pregnant women.
- Patients under guardians or similar legal protection.
The study team makes the final eligibility decision.
Where it's taking place
- Amiens, France
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Amiens, France. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.